We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Direct Oral Anticoagulant Therapy for Isolated Distal Deep Vein Thrombosis Associated with Cancer in Routine Clinical Practice.
- Authors
Ogino, Yutaka; Ishigami, Tomoaki; Sato, Ryosuke; Nakahashi, Hidefumi; Minamimoto, Yugo; Kimura, Yuichiro; Okada, Kozo; Matsuzawa, Yasushi; Iwahashi, Noriaki; Hibi, Kiyoshi; Kosuge, Masami; Ebina, Toshiaki; Ishikawa, Toshiyuki; Tamura, Kouichi; Kimura, Kazuo
- Abstract
Background: The efficacy and bleeding complications of direct oral anticoagulant (DOAC) therapy for isolated distal deep vein thrombosis (IDDVT) associated with cancer in routine clinical practice remain unclear. Moreover, prior studies on prolonged therapy for IDDVT are limited. Methods: This retrospective study enrolled 1641 consecutive patients with acute venous thromboembolism (VTE) who had received oral anticoagulant therapy, including warfarin or DOAC, between April 2014 and September 2018 in our institutions. In these patients, 200 patients with cancer-associated IDDVT were evaluated. Results: Mean follow-up period was 780 ± 593 days. Major bleeding and VTE recurrence were observed in 22 (11.0%) and 11 (5.5%) patients, respectively. In multivariate analysis, statistically significant factors correlated with major bleeding were advanced cancer stage, high performance status, stomach cancer, and gallbladder cancer; those correlated with all-cause death were advanced cancer stage, high performance status, liver dysfunction, pancreatic cancer, and major bleeding. Cumulative events of major bleeding and recurrence between patients with prolonged DOAC therapy (≥90 days) and those with nonprolonged therapy were not significantly different. Conclusions: Preventing major bleeding is important because it is a significant risk factor for all-cause death. Major bleeding and recurrent events were comparable between prolonged and nonprolonged therapy.
- Subjects
VENOUS thrombosis; GALLBLADDER cancer; DISEASE relapse; ANTICOAGULANTS; HEMORRHAGE; STOMACH cancer
- Publication
Journal of Clinical Medicine, 2021, Vol 10, Issue 20, p4648
- ISSN
2077-0383
- Publication type
Article
- DOI
10.3390/jcm10204648